Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Miltefosine

EU orphan designation number: EU/3/05/282   
Active ingredient: Miltefosine
Indication: Treatment of Acanthamoeba keratitis
Sponsor: Orphanidis Pharma Research GmbH
Wilhelminenstraße. 91 IIf, A-1160 Wien, Österreich

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/05/2005 Centralised Orphan - Designation EMEA/OD/007/05 (2005)1661 of 27/05/2005
29/05/2007 Other procedure
12/07/2007 Centralised Orphan - Transfer of orphan designation EMEA/OD/007/05/T/01 (2007)3434 of 10/07/2007
10/12/2008 Centralised Orphan - Transfer of orphan designation EMEA/OD/007/05/T/02 (2008)8160 of 04/12/2008